Quarterly report pursuant to Section 13 or 15(d)

Loans Receivable - Components (Details)

v3.23.1
Loans Receivable - Components (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable $ 13,582   $ 11,456
Less allowance for expected credit losses (7,625)   (7,237)
Loans receivable, net of expected credit losses 5,957   4,219
Less current portion of loan receivable (252)   (516)
Loans receivable, long-term 5,705   3,703
Accrued interest receivable $ 132    
Financing Receivable, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Less current portion of loan receivable    
Interest and Fee Income, Loans and Leases $ 64 $ 4  
Additional allowance for credit losses 388    
Teneo Fund SPVi LLC note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable 5,911   5,911
Pharma EU, LLC note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable 1,410   1,410
A&R note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable 710   710
SSZ and Elev8 note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable 1,002   1,002
Pure Hana Synergy note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable 224   224
Little Beach Harvest Note      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Total loans receivable $ 4,325   $ 2,199
Interest rate on loans receivable 9.00%